# A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis

> **NCT00246259** · PHASE4 · COMPLETED · sponsor: **Janssen-Ortho Inc., Canada** · enrollment: 77 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder
- Schizophreniform Disorder
- Psychotic Disorders

## Interventions

- **DRUG:** Risperidone long-acting injection (LAI)
- **DRUG:** Oral Antipsychotic

## Key facts

- **NCT ID:** NCT00246259
- **Lead sponsor:** Janssen-Ortho Inc., Canada
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2013-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00246259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00246259, "A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00246259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*